Clinical trials
Trials in Kazakhstan with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 8 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 11 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 13 |
| Recruiting | 11 |
| Active, not recruiting | 5 |
| Not yet recruiting | 4 |
| Enrolling by invitation | 3 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astana Medical University | 7 |
| The Society of Bariatric and Metabolic Surgeons of Kazakhstan | 7 |
| Columbia University | 6 |
| Kazakh Eye Research Institute | 5 |
| National Research Center for Cardiac Surgery, Kazakhstan | 4 |
| Tulip Medicine | 4 |
| University Medical Center, Kazakhstan | 4 |
| Asfendiyarov Kazakh National Medical University | 3 |
| Karaganda Medical University | 3 |
| Nazarbayev University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 11 |
| Heart Failure | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| COVID-19 | 5 |
| Obesity, Morbid | 4 |
| Overweight | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Atherosclerosis | 2 |
| Gastroesophageal Reflux | 2 |
| Glaucoma | 2 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.